A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that ...

Due to the broad landscape of treatments for alopecia areata, we wanted to know the potential benefits and harms of the available treatments and to see if some of them work better than others. What ...

Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...

Sun Pharmaceutical Industries Limited announced Leqselvi (deuruxolitinib) 8 mg tablets is now available to healthcare providers and people living with severe alopecia areata in the US. Leqselvi is ...

The delay in Sun Pharma's launch of Leqselvi in the US was caused by a patent infringement case, which was later settled in a ...

Mumbai: Sun Pharmaceutical Industries Limited has announced the launch of LEQSELVI (deuruxolitinib) 8 mg tablets in the U.S.

LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients MUMBAI, India and ...

That same month, she served as a speaker at the 40th annual National Alopecia Areata Foundation conference in Chicago. Currently, Latimer is looking forward to having more down time with friends and ...

to help raise awareness about alopecia with the National Alopecia Areata Foundation. After breaking a DCC rule by bringing an unknown man into her hotel room during a team trip to the Bahamas, veteran ...

Key takeaways Nicole Friedland (Merrill ’89, community studies) is the President and CEO of the National Alopecia Areata Foundation. Brett King (Crown ’92, chemistry) is a renowned dermatologist who ...

Alopecia is a special phenotype in drug safety evaluations. Anagen effluvium, telogen effluvium, alopecia areata (AA), and scarring alopecia may all potentially related to medications. The underlying ...

The annual national Alopecia Areata Conference takes place this week in Chicago. Dr. King will be on hand to discuss JAK inhibitors. Sign up for our Medical Watch newsletter.